Planejamento, síntese e avaliação farmacológica de novos candidatos a protótipos de fármacos anti-inflamatários, desenhados a partir do nerolidilcatecol

• Autor(a) principal: MARTINS, Fabiula Ines
• Data de Publicação: 2009
• Tipo de documento: Dissertação
• Idioma: por
• Título da fonte: Repositório Institucional da UFG
• Texto Completo: http://repositorio.bc.ufg.br/tede/handle/tde/2131
• topic: fosfolipase A2, anti-inflamatórios, rotas sintéticas; phospholiase A2, anti-inflammatory drugs, synthetic routes; CNPQ::CIENCIAS DA SAUDE::FARMACIA

Inflammation is a local reaction of tissue involving neurological, vascular, humoral and cellular reactions to eliminate the causal agents and reduce the cellular damages. Prostaglandins, thromboxanes and leukotrienes are examples of chemical inflammation mediators, resulting for the action of the enzyme phospholipase A2 (PLA2). The PLA is a enzyme that hydrolyses membrane phospholipids in the sn-2 position resulting in lisophospholipids and arachidonic acid (AA), taking a key role in the production of lipidic inflammatory mediators. The research and development of new chemical entities security, effective and that presents less side effects to the particular therapeutic target, constituted the principal objective of technological innovation in pharmaceuticals industry. Due the side effects of selective inhibitors of the production of eicosanoids currently presents in the market, control of production of AA by inhibiting PLA2 is a useful treatment for pathological conditions that are caused by mediators of the AA. In this work synthetic routes were studied to obtain new candidates prototypes of anti-inflammatory drugs obtained by rational planning of new piperazines derivatives originally designed from nerolidylcatechol (25) and arilsulfonilpiperazines (26) to presents the inhibitory profile of secreted PLA2 enzyme. The final synthesized compound, N-(benzo[d][1,3]dioxol-5-aryl) acetamide (18), E-N-(3,7-dimetylocta-2,6-dienyl) benzo[d] [1,3]dioxol-5-amine (19), (E)-N-(6-dienil,3,7-dimetilocta-2)aminobenzeno (20), (E)-4-(6-dienil,3,7-dimetilocta-2)(aminometil)fenol (21) e (E)-(N)-(6-dienil,3,7-dimetilocta-2)-N-(4-idroxifenil)metanosulfanoamida (22) were submitte to in vitro pharmacological assays to evaluated the enzymatic inhibition of sPLA2 and characterization by hydrogen nuclear magnetic resonance (RMN 1H) and the 13 carbon nuclear magnetic resonance (RMN 13C). Based on the obtained results by pharmacological assays can be concluded that the final synthesized compounds (18, 19, 21, 22) presents good anti-inflammatory profiles. As the synthetic methods employed to obtain the final molecules (18-22) the results showed be viable in its execution enable an obtainment of compounds with appropriate yields and efficiency in the profile of purification